CIK 0001521036 · Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352318913
- Phone
- 978 671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- 4 Open-market sale 10% owner sold 78,145 shares at $3.14 ($245,610)
- 4 Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- PREM14A Deal PREM14A
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Executive or director change
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SD Other Specialized Disclosure
Page 2 of 57 · 1,121 filings